Department of Hematology and Medical Oncology, University of Missouri-Columbia, USA.
Clin Lung Cancer. 2011 Mar;12(2):87-93. doi: 10.1016/j.cllc.2011.03.002. Epub 2011 Apr 8.
The history of small-cell lung cancer (SCLC) is one of the more fascinating stories of medicine, a story of hope and disappointment that characterizes it as 1 of the most elusive cancers. Its history can be divided into 3 intervals. The first interval encompassed the 30 years after the initial reports from Bernard in 1926 during which SCLC was characterized. The second interval, from the 1960s-1980s, introduced advances in staging and treatment of SCLC and the advent of chemotherapy and radiation therapy (RT) as the primary forms of therapy. The final interval covers the past 25 years, which is considered a dormant period, although there are some shimmers of hope from the emergence of several new active drugs that are currently undergoing clinical trials.
小细胞肺癌(SCLC)的历史是医学上一个更引人入胜的故事之一,它充满了希望和失望,是最难以捉摸的癌症之一。它的历史可以分为三个阶段。第一阶段涵盖了 1926 年 Bernard 最初报道后的 30 年,在此期间 SCLC 的特征得到了描述。第二阶段,从 20 世纪 60 年代到 80 年代,引入了 SCLC 的分期和治疗的进展,以及化疗和放疗(RT)作为主要治疗形式的出现。最后一个阶段涵盖了过去的 25 年,尽管有一些新的有效药物的出现带来了一些希望,这些药物目前正在临床试验中。